Whitnell & Co’s GSK GSK Stock Holding History

Whitnell & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Hold	88	–	–	﹤0.01%	262
2019 Q3	$5K	Hold	88	–	–	﹤0.01%	261
2019 Q2	$4K	Hold	88	–	–	﹤0.01%	241
2019 Q1	$5K	Buy	+88	New	+$4.4K	﹤0.01%	245
2018 Q3	–	Sell	-114	Closed	-$6K	–	290
2018 Q2	$6K	Hold	114	–	–	﹤0.01%	254
2018 Q1	$6K	Buy	114 +87	+322%	+$4.05K	﹤0.01%	281
2017 Q4	$1K	Buy	+27	New	+$1.25K	﹤0.01%	351
2017 Q1	–	Sell	-248	Closed	-$12K	–	302
2016 Q4	$12K	Hold	248	–	–	0.01%	236
2016 Q3	$13K	Hold	248	–	–	﹤0.01%	224
2016 Q2	$13K	Hold	248	–	–	﹤0.01%	228
2016 Q1	$13K	Buy	248 +47	+23%	+$2.34K	﹤0.01%	224
2015 Q4	$10K	Hold	201	–	–	﹤0.01%	238
2015 Q3	$10K	Buy	+201	New	+$10.5K	﹤0.01%	228

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Whitnell & Co's GSK Position: Q4 2019 in Review

Whitnell & Co held its GSK (GSK) position steady in Q4 2019 at 88 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Whitnell & Co first reported a position in GSK in Q3 2015 and has held it in 13 quarters since. The position peaked at $13K in Q3 2016. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Whitnell & Co held 88 shares of GSK worth $5K as of Q4 2019.
Whitnell & Co left its GSK share count unchanged in Q4 2019.
GSK made up ﹤0.01% of Whitnell & Co's portfolio in Q4 2019, its #262 holding.
Whitnell & Co first reported a position in GSK in Q3 2015 and has held it in 13 quarters since.
Whitnell & Co's GSK position peaked at $13K in Q3 2016.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.